Franklin Genomic Advancements ETF
HELX
Closed
$40.13
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
HELX was created on 2020-02-25 by Franklin. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 25.12m in AUM and 62 holdings. HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.
Company
Franklin
Asset class
Equity
Inception date
2020
Investment segment
Theme
ISIN
US35473P5200
Website
Key stats
Open
$40.51
Volume
12.43K
AUM
$30.80M
Prev. close
$40.18
Expense ratio
0.50%
P/E
33.05
$39.93
Day’s Range
$40.51
$31.24
52W Range
$41.30
What’s in the fund
4
Total sectors
Health Care
86.40%
Materials
3.03%
Information Technology
2.44%
Others
8.13%
Returns
Performance
_
Difference
_
Franklin Genomic Advancements ETF
Jan
8
Dividends
The last payment date was Jan 8, 2026
Div. per Share
$0.14
Div. Yield
0.35%
Div. Growth YoY
21.39%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply